Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn:
“How can we be more efficient in early drug development?
Operational excellence in biopharma research and early development.”
Other articles featuring Vivek Subbiah on OncoDaily.